AGC Biologics is a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of complex biologics, including therapeutic proteins, plasmid DNA, messenger RNA, viral vectors, and genetically engineered cells. With a strong presence across the U.S., Europe, and Asia, AGC Biologics operates cGMP-compliant facilities in multiple locations, ensuring high-quality standards in biopharmaceutical manufacturing. The company's mission emphasizes partnership and collaboration with clients to address their unique challenges, particularly in fast-track projects and rare diseases. AGC Biologics values continuous innovation and technical expertise, fostering a culture dedicated to professional development and teamwork, making it a reliable choice for companies looking for comprehensive biopharmaceutical solutions.